| MAGLE CHEMOSWED HOLDING |
| Schweden |
| Gesundheit |
| SE0014401014 / A2P71A |
| 52X (Frankfurt) |
| FRA:52X, ETR:52X, 52X:GR |
| - |
| https://maglechemoswed.co.. |
|
Magle Chemoswed Holding AB is a Swedish-based company operating within the pharmaceutical and healthcare industry, known for its specialized focus on the development and manufacturing of complex chemical products and innovative drug delivery systems...
>Volltext.. |
| 7.95 Mio. EUR |
| 37.86 Mio. EUR |
| 26.83 Mio. EUR |
| 4.93 Mio. EUR |
| -2.44 Mio. EUR |
| -0.12 EUR |
| 31.02 Mio. EUR |
| 1.08 Mio. EUR |
| -7.37 Mio. EUR |
| 0.08 |
| 41.83% |
| -258.82% |
| - |
| - |
| - |
| - |
| MAGLE CHEMOSWED, MAGLECHEMOSWED |
| 05.04.26 |
|